Rapid Rescue wash: the Clearasil headline and its dated label

The official US page names Rapid Rescue Deep Treatment Wash, Normal to Oily Skin, 6.78 fl oz. It identifies salicylic acid 2% and describes an acne-treatment wash. The label panel likewise names Rapid Rescue Deep Treatment Wash and pairs 6.78 fl oz with 200 mL. Manufacturer page and package panel.

Those fields identify the reviewed item more precisely than a broad acne-wash category. The version-and-label guide explains why the complete name and package description should travel together. A stated container size is not proof of what a particular transaction supplied, and it does not describe a treatment duration or establish how long the contents would last.

Both sources state the salicylic active and provide inactive lists. They name water, glycerin, several cleansing ingredients, fragrance and botanical extracts. The lists correspond closely, including the same general formula components, though the spelling of the lavender entry differs between the website and label text. Website declaration and label declaration.

This comparison concerns the published records, not an independently analyzed tube. It also does not prove a predictable response to the mixture. The 2% comparison guide develops why the active figure leaves other questions open. A full list adds identity information without becoming a recipe, a measure of individual exposure or evidence that this wash outperforms another finished preparation.

The ingredient-and-appearance table calls the product a salicylic acid lotion. Elsewhere, the package name says wash and the label describes rinsing. That combination establishes a washing role rather than a leave-on cream, even while the structured field remains part of the posted record. Form and label wording.

The review does not rewrite the table or derive instructions from the discrepancy. It states why one isolated term cannot settle the entire product identity. The Obagi record review is another place to examine precise format language. These links concern reading product records; they are not directions to exchange a wash for a toner or calculate equivalent use between forms.

The website advertises visibly clearer skin in as little as 12 hours. The label panel repeats rapid visible-result wording and also says the product starts working instantly. These are explicit manufacturer claims, but the reviewed texts do not identify the participants, comparator or outcome definition behind them. Rapid headline and label panel.

The two phrases do not demonstrate separate studies or establish when a specific lesion will improve. Nor does the manufacturer’s description of medication being deposited into pores identify a counted pore-clearance result. A useful evidence question asks what was measured and in whom. It keeps the claim visible without inventing a clinical deadline or assuming every visible concern has the same cause.

The posted record was updated May 13, 2026 and identifies Reckitt Benckiser LLC. Its NDC identifies the Rapid Rescue record, while the package information identifies a 200 mL tube. Those facts improve traceability, but they do not prove which tube is currently on a store shelf. Reckitt label identity.

FDA cautions that an NDC does not denote approval and that listing does not establish agency verification of the submitted information. FDA directory limits. The distinction matters when a detailed public record looks authoritative: its value here is locating the exact submitted label. It is not a clinical score, an independent compliance audit or confirmation of a completed sale.

The website and label warn about irritation and dryness, particularly in their discussion of other topical acne medication. That context remains important despite the rapid-result advertising. It does not predict an individual reaction, and the review does not reproduce the accompanying application schedule or combine it with another product’s instructions. Manufacturer warnings and label warnings.

A favorable headline and a warning address different aspects of the same preparation. Neither should be selected to erase the other. The Versed review provides a separate discussion of attributed appearance and comfort outcomes. This navigation does not establish an equivalence between products or a safer choice for an individual.

The strongest documented facts are the named wash, active, full declaration and dated package record. The strongest unresolved evidence question concerns the meaning and method behind the rapid-result claim. No current price, stock, supplied tube or checkout was verified for this review. Product record and posted label.

FDA distinguishes product identity, quantity and changing labeling information in its consumer explanation. FDA label context. The cream-and-alternatives comparison helps keep those fields separate. A document can make an offer easier to identify without establishing personal efficacy, converting the tube into months of treatment or turning promotional timing into a recommendation.